Patrick J. Scannon,Alan M. Solinger,Jeffrey D. Feldstein
申请号：
US15647203
公开号：
US10611832B2
申请日:
2017.07.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed are methods for the reduction, prevention or treatment of cardiovascular events and/or cardiovascular diseases, including acute cardiovascular disease or chronic cardiovascular disease using anti-IL-1β binding molecules (e.g., IL-1β binding antibodies and fragments thereof). The present disclosure also relates to methods for prevention or treatment of cardiovascular events and/or cardiovascular diseases, including by reducing a cardiovascular event or disease.
